Latest Shareholder Meetings News

Alkane Resources has secured Swedish regulatory approval for its proposed merger with Mandalay Resources, advancing a significant consolidation in the gold and antimony mining sector. The deal now awaits further approvals before shareholder votes expected in July.

Wiseway Group Limited will seek retrospective shareholder approval for critical related party leases after ASX determines prior approvals were required. The company assures operations remain unaffected as it commissions an independent fairness report.

Carbine Resources has successfully raised $1.78 million through a pro-rata entitlement offer and shortfall placement, setting the stage for further shareholder approval in August.

FireFly Metals has filed a final prospectus for a C$25.7 million bought deal offering as part of a broader A$71 million equity raise to advance its high-grade copper-gold projects in Canada. The capital raise includes institutional placements, a charity flow-through placement, and a share purchase plan.

PointsBet has released a supplementary scheme booklet revealing an improved $1.20 per share cash offer from MIXI, alongside a postponed shareholder meeting now set for June 25. The deal, backed unanimously by the PointsBet board, faces final court and regulatory approvals.

Patrys Limited has formalized the redundancy of CEO Dr James Campbell, with a $535,877 payout partly converted into shares pending shareholder approval. Dr Campbell will continue as a non-executive director.

Vulcan Steel announces a significant leadership transition with CEO Rhys Jones retiring after nearly two decades, handing the reins to Gavin Street from January 2026. The board reshuffle also sees Jones moving to non-executive Chair, ensuring continuity at the top.

Silk Logistics Holdings has announced a court-ordered postponement of the Scheme Meeting for its acquisition by DP World Australia, delaying shareholder decisions and the acquisition timeline.

PointsBet Holdings has formalised a conditional takeover bid deed with MIXI at $1.20 per share, activating if shareholders reject the current scheme of arrangement. The deal hinges on key regulatory approvals and a minimum 50.1% acceptance threshold.

Mayne Pharma rejects Cosette Pharmaceuticals’ claims of valid termination of their scheme deal, setting the stage for a September court showdown while urging shareholders to back the scheme in June.

Mayne Pharma has dismissed a fresh termination notice from Cosette Pharmaceuticals, reaffirming its commitment to proceed with the upcoming Scheme Meeting on 18 June 2025. The dispute centers on the validity of the Scheme Implementation Deed termination claims.

Yowie Group Ltd has initiated an off-market takeover bid to acquire Keybridge Capital Limited, offering one Yowie share for each Keybridge share amid Keybridge's financial distress and administration history.